Company: BNBX
Filing Date: 2025-04-04
Form Type: PRE 14A
Source: 0001104659-25-032262
Chunk: 39

Company: BNB PLUS CORP.
Filing Date: 2025-04-04
Form: PRE 14A
Chunk 39
---
-Hallum ” or the “ Placement Agent ”) acted as placement agent in connection with the Offering. Pursuant to that certain engagement letter, dated August 23, 2024, by and between the Company and the Placement Agent (the “ Engagement Letter ”), the Company paid the Placement Agent a cash placement fee equal to 6.0% of the aggregate gross proceeds raised in the Offering from sales arranged for by the Placement Agent. Subject to certain conditions, the Company also reimbursed certain expenses of the Placement Agent in connection with the Offering, including but not limited to legal fees, up to a maximum of $100,000. The Company also issued to the Placement Agent, or its respective designees, Placement Agent Warrants (“ Placement Agent Warrants ”) to purchase up to 20,313 shares of Common Stock (which equals 5.0% of the number of shares of Common Stock and Pre-Funded Warrants offered in the Offering). The Offering closed and the Private Placement Warrants were issued on October 31, 2024. The Company received gross proceeds from the Offering, before deducting placement agent fees and other estimated offering expenses payable by the Company, of approximately $6.5 million. The exercisability of the Private Placement Warrants will be available only upon receipt of such stockholder approval (the “ Warrant Stockholder Approval ”) as may be required by the applicable rules and regulations of The Nasdaq Stock Market LLC. Each Series C Warrant has an exercise price of $16.00 per share of Common Stock, will become exercisable upon the first trading day following the Company’s notice to warrantholders of Warrant Stockholder Approval (the “ Stockholder Approval Date ”), and will expire on the five-year anniversary of the Stockholder Approval Date. Each Series D Warrant has an exercise 25 TABLE OF CONTENTS price of $16.00 per share of Common Stock, will become exercisable upon the Stockholder Approval Date, and will expire on the 18-month anniversary of the Stockholder Approval Date. Each Placement Agent Warrant has an exercise price of $16.00 per share of Common Stock, will become exercisable upon the Stockholder Approval Date and will expire on October 30, 2029. Upon the receipt of Warrant Stockholder Approval, if all Private Placement Warrants are exercised as described in the immediately preceding paragraph (including if the Series D Warrants are exercised pursuant to the alternative cashless exercise mechanism described below), the Company will have 19